Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Use of Midazolam and Remifentanil During Arteriovenous Fistula Placement Procedure and Monitored Anesthesia Care

NCT04226443 is registered in ClinicalTrials.gov with Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital as lead sponsor.

NCT NCT04226443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04226443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Use of Midazolam and Remifentanil During Arteriovenous Fistula Placement Procedure and Monitored Anesthesia Care
Lead sponsor
Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Phase
Not applicable
Overall status
Completed
Start date
August 28, 2012
Completion date
April 30, 2016
Enrollment
99 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

adverse reaction to drug, analgesic adverse reaction, arteriovenous fistula, chronic kidney diseases, midazolam adverse reaction, patient satisfaction, sedative adverse reaction